ArticleJournal of eating disorders2026
How can community pharmacists support people living with eating disorders? identifying evidence gaps and practice opportunities in Australia.
Article in Journal of eating disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eating disorders (EDs) are mental illnesses which greatly contribute to disease burden. While binge-eating disorder is the most common ED, anorexia nervosa accounts for one of the most life-threatening mental illnesses. People living with EDs often wait years before receiving a diagnosis and medical support, consequently experiencing poorer health outcomes and longer hospital admissions. As frontline healthcare workers, pharmacists are amongst the most accessible and trusted healthcare professionals. Pharmacists' roles in mental healthcare are expanding with recent evidence demonstrating their contribution to mental health screening and medication management. Pharmacies are frequently visited by the community, reflecting the potential opportunities for pharmacists to be trained to engage with and provide support to people experiencing EDs and their carers. Furthermore, considering people living with EDs have altered pharmacokinetics and may benefit from tailored medication counselling and advice, pharmacists' expertise in medicines and their skills in supporting medicine use may be especially important in this population group. This commentary highlights evidence gaps, and ways trained pharmacists may contribute to supporting people living with EDs. It is evident that there is a need for research exploring pharmacists' current contribution to ED care, the co-design of training to upskill the community pharmacy workforce in providing ED care, and the feasibility and impact of pharmacist-delivered support for people experiencing EDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.